Metis Global Partners, LLC Laboratory Corp Of America Holdings Transaction History

Metis Global Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$209.01 - $232.56 $15,048 - $16,744	-72 Reduced 1.69%	4,200 $917,000
Q4 2023 Feb 06, 2024	SELL	$197.69 - $227.29 $70,377 - $80,915	-356 Reduced 7.69%	4,272 $970,000
Q3 2023 Nov 07, 2023	BUY	$201.05 - $221.7 $156,617 - $172,704	779 Added 20.24%	4,628 $930,000
Q2 2023 Aug 07, 2023	BUY	$211.93 - $241.33 $36,451 - $41,508	172 Added 4.68%	3,849 $928,000
Q1 2023 May 08, 2023	BUY	$213.32 - $257.83 $359,870 - $434,959	1,687 Added 84.77%	3,677 $843,000
Q4 2022 Feb 07, 2023	BUY	$203.72 - $248.97 $107,360 - $131,207	527 Added 36.02%	1,990 $468,000
Q3 2022 Nov 08, 2022	BUY	$204.81 - $262.19 $2,867 - $3,670	14 Added 0.97%	1,463 $299,000
Q2 2022 Aug 08, 2022	SELL	$213.86 - $277.87 $13,900 - $18,061	-65 Reduced 4.29%	1,449 $340,000
Q1 2022 May 03, 2022	BUY	$259.82 - $298.18 $173,819 - $199,482	669 Added 79.17%	1,514 $399,000
Q4 2021 Feb 11, 2022	BUY	$271.6 - $314.21 $229,502 - $265,507	845 New	845 $266,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $22.1B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Metis Global Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Metis Global Partners, LLC with notifications on news.